IL6 and ovarian carcinoma: Although IL-6 has potential as a biomarker for discriminating healthy individuals from ovarian cancer patients, our findings reveal its limited utility in distinguishing benign from malignant ovarian conditions, a finding also reported by Kampan et al. [66].